Evidence map›Paper›PMID 36346879›Full record

ArticleBlood transfusion = Trasfusione del sangue2023

Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage.

Anne-Claire Duchez, Sébastien Fauteux-Daniel, Theo Ebermeyer, Marco Heestermans, Charles-Antoine Arthaud, Marie-Ange Eyraud, Amélie Prier, Estelle Audoux, Jean-Charles Portais, Justine Bertrand-Michel and 4 more

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Anne-Claire DuchezEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Sébastien Fauteux-DanielEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Theo EbermeyerUniversity of Jean Monnet, Mines Saint-Étienne, INSERM, U 1059 SAINBIOSE, Saint-Étienne, France.
Marco HeestermansEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Charles-Antoine ArthaudEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Marie-Ange EyraudEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Amélie PrierEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Estelle AudouxEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Jean-Charles PortaisMetaToul-Lipidomic MetaboHUB Core Facility, Inserm, U1048, Toulouse France.
Justine Bertrand-MichelMetaToul-Lipidomic MetaboHUB Core Facility, Inserm, U1048, Toulouse France.
Olivier GarraudEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Hind Hamzeh-CognasseUniversity of Jean Monnet, Mines Saint-Étienne, INSERM, U 1059 SAINBIOSE, Saint-Étienne, France.
Eric BoilardDepartment of Infectious Diseases and Immunity, Centre de Recherche du CHU de Québec, Canada.
Fabrice CognasseEtablissement Français du Sang Auvergne-Rhône-Alpes, Saint-Étienne, France.
Établissement Français du Sang · FRCentre Hospitalier Universitaire de Toulouse · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStructural and biochemical changes in stored platelets are influenced by collection and processing methods. Lesions may appear during platelet concentrate storage, some of which may be involved in adverse transfusion reactions. The preparation and storage of platelet concentrates (PC) may modify and even damage the lipid mediator content. The aim of this study was to investigate the lipidomic profile identified in the supernatants of PCs according to processing and storage conditions, both after leukocyte filtration and contained in platelet additive solution (PAS), comparing single donor apheresis (SDA) products with pooled buffy coat (BC) products. MATERIALS AND

methodsWe investigated the accumulation of various lipid mediators including lysophospholipids (LP) and eicosanoids in SDA and BC products stored for 0-5 days. All products were processed following French Blood Establishment (EFS) procedures in accordance with EDQM/GTS European Standards. Both SDA and BC were leukocyte reduced and conserved in 35% autologous donor plasma and 65% platelet additive solution. Lipidomic analysis was performed on PC supernatants using LS/MS spectrometry.

resultsOur data demonstrate that lysophosphatidylcholine (LPC) levels were higher in BCs compared to SDAs, with no difference in lysophosphatidic acid (LPA) expression between the two preparation methods. Results for other eicosanoids showed greater similarity; indeed, no clear pattern emerged from analysis of eicosanoids in terms of storage time and process. In general, we observed longitudinal lipid mediator modulation for both SDAs and BCs, particularly at later time points. DISCUSSION: The expression of LPC and some eicosanoids in BCs could be used as novel biomarkers of PC quality. Future studies are needed to explore their impact on adverse transfusion reactions.

Indexed as

Blood Component RemovalLipidomicsBlood PlateletsBlood PreservationHumansLipidsPlatelet TransfusionLipids

Identifiers

PMID36346879
PMCPMC10497391
OpenAlexW4308550978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.